©2025 Bryn Mawr Communications, LLC.
All Rights Reserved

Terms and Conditions • Privacy Policy

Meeting Coverage:

American Glaucoma Society

AGS: 2017

Sustained Drug Release

Donald Budenz, MD, MPH

Show Description +

Donald Budenz, MD, MPH, discusses innovations in sustained drug delivery and their potential to mitigate the effects of patients' noncompliance. He addresses the four main challenges related to implementation of these strategies.

Posted: 3/03/2017

Keywords:

Drug Delivery

•

Therapeutic drug delivery

Up Next

OCT Predictions
OCT Predictions

David Huang, MD, PhD

New Paradigm, New Tools
New Paradigm, New Tools

Douglas Rhee, MD

Tube vs Trab: 1-Year Results
Tube vs Trab: 1-Year Results

Steven Gedde, MD

When to Add MIGS to Cataract Surgery
When to Add MIGS to Cataract Surgery

Steven Mansberger, MD, MPH

New Devices on the Horizon
New Devices on the Horizon

Ike Ahmed, MD

Head-to-Head: Ahmed vs. Baerveldt
Head-to-Head: Ahmed vs. Baerveldt

Gene-Based Therapies
Gene-Based Therapies

Home Tonometry's Emerging Role
Home Tonometry's Emerging Role

Arthur Sit, MD

Watch out for Baseline Central Visual Field Damage
Watch out for Baseline Central Visual Field Damage

Glaucoma and Fall Risk
Glaucoma and Fall Risk

Pradeep Yammanuru Ramulu, MD PhD

link-arrow   Back to All Videos

Sustained Drug Release

Donald Budenz, MD, MPH

Donald Budenz, MD, MPH, discusses innovations in sustained drug delivery and their potential to mitigate the effects of patients' noncompliance. He addresses the four main challenges related to implementation of these strategies.

Posted: 3/03/2017

Keywords:

Drug Delivery

•

Therapeutic drug delivery

Please log in to leave a comment.

More From AGS: 2017 Coverage

Gene-Based Therapies
Gene-Based Therapies

Home Tonometry's Emerging Role
Home Tonometry's Emerging Role

Arthur Sit, MD

Watch out for Baseline Central Visual Field Damage
Watch out for Baseline Central Visual Field Damage

Glaucoma and Fall Risk
Glaucoma and Fall Risk

Pradeep Yammanuru Ramulu, MD PhD

Bryn Mawr Communications, LLC, and Eyetube.net are not affiliated with the official program of AGS: 2017.

close-x